ISABEL
CASTREJÓN FERNÁNDEZ
Profesora asociada de Ciencias de la Salud
Radboud University Nijmegen Medical Centre
Nimega, HolandaPublicaciones en colaboración con investigadores/as de Radboud University Nijmegen Medical Centre (4)
2024
-
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice
Seminars in Arthritis and Rheumatism, Vol. 65
2023
-
Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence–Based Data Analyses of a National Multicenter Prospective Registry
Arthritis Care and Research, Vol. 75, Núm. 1, pp. 115-124
-
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
Arthritis and Rheumatology
-
Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network
RMD Open, Vol. 9, Núm. 4